Response to Belgard et al.

por Skafidas, E, Testa, R, Zantomio, D, Chana, G, Everall, I P, Pantelis, C
Publicado 2014

Predicting the diagnosis of autism spectrum disorder using gene pathway analysis

por Skafidas, E, Testa, R, Zantomio, D, Chana, G, Everall, I P, Pantelis, C
Publicado 2014

Response to Belgard et al.

por Skafidas, E, Testa, R, Zantomio, D, Chana, G, Everall, I P, Pantelis, C
Publicado 2014

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia

por Udawela, M, Money, T T, Neo, J, Seo, M S, Scarr, E, Dean, B, Everall, I P
Publicado 2015

Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia

por Mostaid, M S, Mancuso, S G, Liu, C, Sundram, S, Pantelis, C, Everall, I P, Bousman, C A
Publicado 2017

Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations

por Liu, C, Bousman, C A, Pantelis, C, Skafidas, E, Zhang, D, Yue, W, Everall, I P
Publicado 2017

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk

por Saini, S M, Mancuso, S G, Mostaid, Md S, Liu, C, Pantelis, C, Everall, I P, Bousman, C A
Publicado 2017

COMT Val158Met Polymorphism, Executive Dysfunction, and Sexual Risk Behavior in the Context of HIV Infection and Methamphetamine Dependence

por Bousman, C. A., Cherner, M., Atkinson, J. H., Heaton, R. K., Grant, I., Everall, I. P., HNRC Group, The
Publicado 2010

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

por Bousman, C A, Yung, A R, Pantelis, C, Ellis, J A, Chavez, R A, Nelson, B, Lin, A, Wood, S J, Amminger, G P, Velakoulis, D, McGorry, P D, Everall, I P, Foley, D L
Publicado 2013

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue

por Lai, C-Y, Lee, S-Y, Scarr, E, Yu, Y-H, Lin, Y-T, Liu, C-M, Hwang, T-J, Hsieh, M H, Liu, C-C, Chien, Y-L, Udawela, M, Gibbons, A S, Everall, I P, Hwu, H-G, Dean, B, Chen, W J
Publicado 2016

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

por Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Publicado 2017

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

por Okhuijsen-Pfeifer, C., van der Horst, M. Z., Bousman, C. A., Lin, B., van Eijk, K. R., Ripke, S., Ayhan, Y., Babaoglu, M. O., Bak, M., Alink, W., van Beek, H., Beld, E., Bouhuis, A., Edlinger, M., Erdogan, I. M., Ertuğrul, A., Yoca, G., Everall, I. P., Görlitz, T., Grootens, K. P., Gutwinski, S., Hallikainen, T., Jeger-Land, E., de Koning, M., Lähteenvuo, M., Legge, S. E., Leucht, S., Morgenroth, C., Müderrisoğlu, A., Narang, A., Pantelis, C., Pardiñas, A. F., Oviedo-Salcedo, T., Schneider-Thoma, J., Schreiter, S., Repo-Tiihonen, E., Tuppurainen, H., Veereschild, M., Veerman, S., de Vos, M., Wagner, E., Cohen, D., Bogers, J. P. A. M., Walters, J. T. R., Yağcıoğlu, A. E. Anil, Tiihonen, J., Hasan, A., Luykx, J. J.
Publicado 2022